Home
Woodline Partners reported a 4.8% stake in Sagimet Biosciences SGMT · 1,501,357 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.8%
- Last report
- 8.3% · filed 25/08/14
- Shares held
- 1,501,357 sh
- Class
- Series A Common Stock, par value $0.0001 per share
- Holder
- Woodline Partners
- Event date
- 25/09/30
- Filed
- 25/11/14
4.8% stake · below 5%
- Stake
- 4.8%
- Last report
- 8.3%
- Since last report
- −3.5pp
Sagimet Biosciences trades, last 26 weeks
What else happened in Sagimet Biosciences around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Woodline Partners's other 5% stake reports
- Woodline Partners
5% stakeZevra Therapeutics
5% stakeZevra Therapeutics
ZVRA
8.1% stake
4,785,771 sh
8.1% stake
Filed 08/14
- Woodline Partners
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
2.5% stake
4,000,567 sh
2.5% stake
Filed 08/14
- Woodline Partners
5% stakeSAB Biotherapeutics
5% stakeSAB Biotherapeutics
SABS
6.8% stake
5,455,355 sh
6.8% stake
Filed 08/14
- Woodline Partners
5% stakeCervoMed
5% stakeCervoMed
CRVO
5.1% stake
688,987 sh
5.1% stake
Filed 08/14
- Woodline Partners
5% stakeCalciMedica
5% stakeCalciMedica
CALC
8.1% stake
2,489,729 sh
8.1% stake
Filed 08/14
